|
|||||
|
|
| Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry | |
| 摘 要： | |
| 收稿时间： | 2015-02-25 |